Everything available in the Pharmacist · Researcher tier — daily intake, ZOE voice assessments, MTM audit documentation, PEACS longitudinal tracking, Sentinel follow-up flags, and all export formats. Use the quick-ref card for daily use; come back here when you need to understand a feature in depth.
The Daily Intake Panel is designed for high-volume pharmacy practice — logging multiple patients per session without running a full MMAS-8 assessment on every one. It sits at the top of your dashboard and is collapsed by default. Click the header bar to expand it.
| Situation | Use |
|---|---|
| Quick check-in — patient picking up refill, 60 seconds available | Daily Intake Panel (rapid 3-item screen) |
| New patient, first adherence assessment, 5–10 minutes available | New Assessment → full MMAS-8 |
| Patient flagged low in rapid screen, needs full assessment today | Daily Intake → tick "Flag for full ZOE" → New Assessment |
| Research study, need complete validated MMAS-8 data for publication | New Assessment → full MMAS-8 always |
The three questions in the Daily Intake Panel are drawn from the full MMAS-8:
Maximum rapid score is 3. A score below 2 automatically triggers a Sentinel alert and is flagged in the MTM audit log for follow-up. This is not a validated standalone instrument — use it for triage only. The full MMAS-8 is required for any published research.
ZOE (an AI voice agent powered by Claude) guides patients through the full MMAS-8 verbally. The patient hears each question spoken aloud and responds in natural language. ZOE interprets the response, confirms it back, and moves to the next question. The entire 8-question assessment takes 4–6 minutes.
In a dispensing environment, the best setup is a tablet on a small stand at the counseling window. Hand the patient the tablet with ZOE already open. They tap "Speak" when ready. You can attend to other tasks — you will see the completed assessment in your dashboard when they finish. ZOE handles the entire interaction including the result screen.
If ZOE cannot interpret a patient's response with confidence, it says "Let me make sure I understood you — could you say yes or no for that one?" and waits for clarification before recording the answer. This prevents misscored responses from unclear speech.
If a patient cannot answer a specific question (for example, Q5 about whether they took their medication yesterday, when they started treatment that day), the Skip button records a neutral answer for that question. The final score is calculated on all 8 questions including the skipped one, which is assigned the non-penalising default.
After completing all 8 questions, ZOE automatically generates a clinical SOAP note using the patient's verbatim voice responses and the computed adherence data. The note is ready within 2–3 seconds of the last question.
The SOAP note appears in the result modal after submission. Copy it directly into your pharmacy management system or patient record. Many pharmacists paste it into their dispensing software's notes field. You can also email it to the prescribing physician using the "Send to Researcher" button if your workspace has email notification enabled.
After every ZOE assessment, ATLAS automatically calculates a recommended follow-up date based on the score and pattern:
| Score / Pattern | Interval | Urgency |
|---|---|---|
| INA pattern, clinical flags, or score < 4 | 7 days | Urgent |
| Medium adherence (score 4–6) | 14 days | Moderate |
| High adherence (score > 6) | 30 days | Routine |
A card appears below the ZOE panel after assessment showing the recommended date, the reason for that interval, the patient ID, and the score. The card has two buttons: "Copy reminder link" and "Dismiss."
Clicking "Copy reminder link" generates a URL that pre-fills the ATLAS assessment with your workspace key and the patient ID. Share this with the patient by SMS, email, or WhatsApp. When they open the link and complete a new assessment, their result is automatically added to your cohort under the same Patient ID — enabling longitudinal tracking over time.
The Sentinel system monitors your cohort for adherence events that warrant clinical attention. Alerts appear in the right sidebar of your dashboard.
Click "Mark Reviewed" on any alert card to clear it from the active feed. Reviewed alerts are faded but not deleted — they remain visible in the feed for audit purposes. The "Export Sentinel Log" button at the bottom of the feed exports all alerts (reviewed and active) to CSV.
The MTM Audit Log is a formatted record of every patient encounter in your cohort, with CPT codes auto-suggested based on encounter type and adherence pattern. It sits at the bottom of your dashboard and updates automatically whenever a new assessment is logged.
These are suggestions based on encounter data. Always verify against your specific payer's requirements and your own clinical documentation before billing.
PDF export produces a formatted audit document suitable for CMS auditors, with your workspace name, date range, total encounters, and a formatted table including patient ID, date, CPT code, score, adherence level, pattern, condition, and intervention documented. The document includes the MMAS-8R license reference and ATLAS platform attribution.
CSV export produces a spreadsheet for import into electronic billing systems. Each row is one encounter with all fields as separate columns.
For UK pharmacists: the MUR and NMS consultations document a review of medication usage and adherence. The ATLAS MTM export serves as the structured assessment component of this documentation. For Australian HMR: ATLAS data constitutes the adherence screening component of the clinical assessment. Always check current DVA and PBS requirements.
PEACS (Predictive Emergence Assessment for Clinical Services) measures three behavioural dimensions that together predict whether a patient will sustain adherence over time. The composite PE score is calculated as: PE = (BASE × MVMT × STRATA)^(1/3).
Measures how consistently a patient follows their medication regimen under normal, everyday conditions. A patient with high BASE takes their medication reliably when nothing disrupts their routine. A patient with low BASE struggles even in stable circumstances — often indicating habit not yet formed or significant avoidance.
Clinical implication: Low BASE suggests the patient needs structured habit-formation support — linking medication to an existing daily anchor (meals, brushing teeth, bedtime).
Measures whether a patient maintains adherence when life changes — travel, illness, shift work, family disruptions, schedule changes. A patient can have high BASE (great at home routine) but low MVMT (falls apart when travelling). This is the most predictive dimension for medication holiday risk.
Clinical implication: Low MVMT patients benefit from a travel kit protocol, pre-loaded pill organisers for trips, and a simple rule for what to do when a dose is missed due to disruption.
Captures the structural barriers and enablers around adherence: housing stability, transport access to pharmacy and clinic, support network quality, health literacy, and beliefs about treatment necessity. Low STRATA almost always co-occurs with Poor PE zone scores.
Clinical implication: Patients with low STRATA need systemic support — pharmacy delivery, social prescribing referral, simplified regimen negotiated with prescriber, or connection to community support services. Clinical counseling alone will not be sufficient.
| Zone | PE Score | Predicted behaviour | Recommended action |
|---|---|---|---|
| Optimal | ≥ 0.85 | High behavioural stability — likely to sustain adherence long-term | Routine monitoring. Positive reinforcement. |
| Good | 0.70–0.84 | Generally stable with occasional instability risk | Periodic check-ins. Address any single low dimension. |
| Moderate | 0.55–0.69 | Instability risk present — may sustain short-term but likely to relapse | Identify which dimension (BASE/MVMT/STRATA) is lowest and target it specifically. |
| Poor | < 0.55 | High risk of sustained non-adherence | Priority intervention. Check STRATA first — often the root cause. Consider social prescribing referral. |
Your dashboard has two main panels (Track A — MMAS-8, Track B — PEACS) plus several additional analytics sections below. Here is what each component shows:
| Component | What it shows | How to use it |
|---|---|---|
| Pulse bar (top) | Live global totals — all ATLAS users worldwide | Context only — not your cohort |
| Mini globe (MMAS) | Map of your cohort's geographic distribution | Visual check of data spread |
| INA / UNA / Mixed / High boxes | Pattern classification breakdown | Hover for clinical tooltip. Determine primary intervention approach for your cohort |
| Adherence Phenotyping Engine | 5-phenotype probabilistic model of your cohort | Population-level intervention planning |
| Drug · Condition Stratification | Mean score by drug class and condition | Identify which drug types have lowest adherence in your population |
| Longitudinal Trajectories | Score over time for patients with 2+ assessments | Monitor individual patient improvement or deterioration over repeat visits |
| Active Patients table | Individual patient records with score, pattern, date | Search by Patient ID. Review individual history. |
| MTM Audit Log | CMS-formatted encounter log with CPT codes | Export for billing reimbursement |
| Export | Format | Contains | Use for |
|---|---|---|---|
| Export MMAS CSV | CSV | All cohort MMAS-8 records with individual Q scores, pattern, demographics, timestamps | Statistical analysis, research publication |
| Export PEACS CSV | CSV | PEACS records with BASE, MVMT, STRATA scores and PE composite | Longitudinal analysis, PEACS research |
| MTM Audit PDF | PDF (print) | Formatted audit table with CPT codes, patient IDs, scores, interventions, license reference | CMS reimbursement, audit documentation |
| MTM Audit CSV | CSV | Same data as MTM PDF in spreadsheet format | Electronic billing system import |
| Sentinel Log CSV | CSV | All sentinel alerts with urgency, reason, patient ID, score, reviewed status | Quality audit, JC documentation |
| SOAP Note | Text (copy/paste) | Individual patient SOAP note from ZOE session | Patient record, prescriber communication |
Your workspace key comes with a Letter of Permission for the MMAS-8R, sent as an HTML attachment in your welcome email. This letter:
MMAS8R-XXXXXXXX-XXXXXXXX-XXXXXXXXTo print your letter: open the attached HTML file in Chrome → File → Print → Save as PDF. Keep a copy in your patient records folder and submit it with any research ethics application.